Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening
- PMID: 15141383
- DOI: 10.1002/path.1564
Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening
Abstract
Hereditary diffuse gastric cancer (HDGC) is a familial cancer syndrome caused, in 30-40% of cases, by germline mutations of the E-cadherin/CDH1 gene. The presence of clinically undetectable early gastric cancers has been previously reported in ten of ten prophylactic gastrectomies from germline E-cadherin mutation carriers. In the present study, detailed maps of the distribution of invasive cancers in nine of these ten stomachs were produced and precursor lesions of HDGC searched for. The nine gastrectomy specimens contained from 1 to 161 foci of early diffuse gastric cancer, occupying 0.005-2.96% of the gastric mucosa. Seven specimens contained focal in situ signet ring carcinoma. Pagetoid spread of signet ring cells was observed beneath the epithelial lining of gastric foveolae/glands. Helicobacter pylori organisms and associated pathology were absent from all cases. Two-dimensional maps of the gastrectomy specimens revealed lesions throughout the gastric mucosa without evidence of antral clustering. The distribution and size of the cancers in the gastrectomy specimens indicate that standard endoscopic screening with random or geographically targeted biopsies is unlikely to provide sufficiently sensitive clinical screening for at-risk individuals. An in situ precursor of signet ring carcinoma was identified and a model for neoplastic progression in the setting of HDGC is proposed.
Copyright 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Similar articles
-
Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.Am J Surg Pathol. 2008 Jun;32(6):799-809. doi: 10.1097/PAS.0b013e31815e7f1a. Am J Surg Pathol. 2008. PMID: 18391748
-
Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk.J Pathol. 2008 Nov;216(3):286-94. doi: 10.1002/path.2415. J Pathol. 2008. PMID: 18825658
-
[From gene to disease; E-cadherin and hereditary diffuse gastric cancer].Ned Tijdschr Geneeskd. 2003 Dec 13;147(50):2474-7. Ned Tijdschr Geneeskd. 2003. PMID: 14708213 Review. Dutch.
-
Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members.Eur J Gastroenterol Hepatol. 2010 Mar;22(3):306-10. doi: 10.1097/MEG.0b013e32832bab9a. Eur J Gastroenterol Hepatol. 2010. PMID: 19474748
-
Hereditary gastric cancer.Pathologe. 2012 Nov;33 Suppl 2:231-4. doi: 10.1007/s00292-012-1677-6. Pathologe. 2012. PMID: 23052347 Review.
Cited by
-
DNA and histone methylation in gastric carcinogenesis.World J Gastroenterol. 2013 Feb 28;19(8):1182-92. doi: 10.3748/wjg.v19.i8.1182. World J Gastroenterol. 2013. PMID: 23482412 Free PMC article. Review.
-
E-cadherin variants associated with oral facial clefts trigger aberrant cell motility in a REG1A-dependent manner.Cell Commun Signal. 2024 Feb 27;22(1):152. doi: 10.1186/s12964-024-01532-x. Cell Commun Signal. 2024. PMID: 38414029 Free PMC article.
-
The role of endoscopy in the management of hereditary diffuse gastric cancer syndrome.World J Gastroenterol. 2019 Jun 21;25(23):2878-2886. doi: 10.3748/wjg.v25.i23.2878. World J Gastroenterol. 2019. PMID: 31249446 Free PMC article. Review.
-
The ECM and tissue architecture are major determinants of early invasion mediated by E-cadherin dysfunction.Commun Biol. 2023 Nov 8;6(1):1132. doi: 10.1038/s42003-023-05482-x. Commun Biol. 2023. PMID: 37938268 Free PMC article.
-
Nature meets nurture: molecular genetics of gastric cancer.Hum Genet. 2009 Nov;126(5):615-28. doi: 10.1007/s00439-009-0722-x. Epub 2009 Aug 6. Hum Genet. 2009. PMID: 19657673 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous